Literature DB >> 1093076

Pilot study on the effect of New Zealand green mussel on rheumatoid arthritis.

T C Highton, A W McArthur.   

Abstract

An extract of the New Zealand green mussel did not show any greater effect than a placebo when given to five patients with rheumatoid arthritis in a double-blind crossover trial.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1093076

Source DB:  PubMed          Journal:  N Z Med J        ISSN： 0028-8446


  3 in total

Review 1.  Systematic review of a marine nutriceutical supplement in clinical trials for arthritis: the effectiveness of the New Zealand green-lipped mussel Perna canaliculus.

Authors:  Christopher S Cobb; Edzard Ernst
Journal:  Clin Rheumatol       Date:  2005-10-12       Impact factor: 2.980

Review 2.  Perna canaliculus and the Intestinal Microbiome.

Authors:  Emma Tali Saltzman; Michael Thomsen; Sean Hall; Luis Vitetta
Journal:  Mar Drugs       Date:  2017-06-30       Impact factor: 5.118

3.  Anti-inflammatory activity of a lipid fraction (lyprinol) from the NZ green-lipped mussel.

Authors:  M W Whitehouse; T A Macrides; N Kalafatis; W H Betts; D R Haynes; J Broadbent
Journal:  Inflammopharmacology       Date:  1997       Impact factor: 5.093
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.